Anrukinzumab (Anti-IL-13)

Ask supplier a question | View on supplier's website

Anrukinzumab (Anti-IL-13) is a humanized monoclonal antibody targeting IL-13. It reduces lung inflammation and can be used in studies of ulcerative colitis (UC) as well as asthma. MW :150 KD.

Supplier	Selleck Chemicals
Product #	A2665
Sku #	A2665-1mg*25
Pricing	1mg*25, $5070.00

Feedback